Literature DB >> 20011646

Lenalidomide-induced acute liver failure.

Pankaj Jain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20011646      PMCID： PMC2782812          DOI： 10.2450/2009.0086-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  4 in total

1.  Lenalidomide-induced severe hepatotoxicity.

Authors:  Subuhee Hussain; Royston Browne; Julie Chen; Samir Parekh
Journal:  Blood       Date:  2007-11-15       Impact factor: 22.113

Review 2.  New drugs in the treatment of myelodysplastic syndromes: are they changing the role of transfusion support?

Authors:  Alberto Grossi; Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2008-10       Impact factor: 3.443

3.  Acute hepatitis B or exacerbation of chronic hepatitis B-that is the question.

Authors:  Efrat Orenbuch-Harroch; Liran Levy; Eldad Ben-Chetrit
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 4.  Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes.

Authors:  Aristoteles Giagounidis; Pierre Fenaux; Ghulam J Mufti; Petra Muus; Uwe Platzbecker; Guillermo Sanz; Larry Cripe; Marie Von Lilienfeld-Toal; Richard A Wells
Journal:  Ann Hematol       Date:  2008-02-12       Impact factor: 3.673
  4 in total
  1 in total

1.  A Case of Drug-Induced Hepatitis due to Lenalidomide.

Authors:  M-C Zanella; L Rubbia-Brandt; E Giostra; Y Chalandon; A Hadengue; L Spahr
Journal:  Case Rep Gastroenterol       Date:  2011-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.